BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28639884)

  • 1. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
    Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
    Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
    Bai PS; Hou P; Kong Y
    Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
    Wang FF; Wang S; Xue WH; Cheng JL
    Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC.
    Wan D; Shen S; Fu S; Preston B; Brandon C; He S; Shen C; Wu J; Wang S; Xie W; Chen B; Liya A; Guo Y; Zheng D; Zhi Q; Peng B
    Anticancer Agents Med Chem; 2016; 16(4):414-23. PubMed ID: 26179263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma.
    Shi C; Xu X
    Biomed Pharmacother; 2013 Jun; 67(5):375-80. PubMed ID: 23582783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
    Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
    Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values.
    Yang S; Cai H; Hu B; Tu J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31164410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z
    Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma.
    Wu XJ; Li Y; Liu D; Zhao LD; Bai B; Xue MH
    Asian Pac J Cancer Prev; 2013; 14(2):885-9. PubMed ID: 23621256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
    He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
    Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-140 represses glioma growth and metastasis by directly targeting ADAM9.
    Liu X; Wang S; Yuan A; Yuan X; Liu B
    Oncol Rep; 2016 Oct; 36(4):2329-38. PubMed ID: 27498787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
    Yang J; Liu X; Yuan X; Wang Z
    Oncol Rep; 2015 Sep; 34(3):1415-23. PubMed ID: 26134929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.
    Wang Y; Cao J; Zhang S; Sun L; Nan Y; Yao H; Fan J; Zhu LY; Yu L
    Cell Death Dis; 2019 Oct; 10(10):783. PubMed ID: 31611549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.
    Wu Q; Liu HO; Liu YD; Liu WS; Pan D; Zhang WJ; Yang L; Fu Q; Xu JJ; Gu JX
    J Biol Chem; 2015 Jan; 290(2):1170-85. PubMed ID: 25422324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis.
    Du J; Bai F; Zhao P; Li X; Li X; Gao L; Ma C; Liang X
    Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):1-11. PubMed ID: 28982593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    Wang ZS; Guo WD; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    PLoS One; 2015; 10(11):e0142727. PubMed ID: 26588210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.